It has been observed in multiple cancers that HDACs promotes the proliferation of cancer cells by reducing the expression of the cyclin-dependent kinase inhibitor p21 or TGF-β, in addition, Class I HDACs can also promote cancer cell metastasis by inhibiting the expression of E-cadherin (Glozak and Seto, 2007). Here, TGFB1 is linked to cancer.